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Background: Dengue is the most common mosquito-borne
infection. About 2.5 billion people are estimated to be at risk of
infection.
Methods & Materials: This is retrospective study curried out
at Kassala Teaching Hospital, eastern Sudan between Augusts to
November 2010, the diagnosis or exclusion of dengue infectionwas
conducted using ELISA IgM serology.
Results: Eighty-one (71.7%) out of 113 patients had con-
ﬁrmed dengue infection at Kassala, Eastern Sudan during the
study period. According to the WHO criteria, dengue fever (DF),
dengue hemorrhagic fever (DHF), and dengue shock syndrome
(DSS) were observed in 30.9, 58, and 11.1% of these patients,
respectively. The mean age of these 81 patients’ was25.5 years.
Male: female ratio was 1.8:1. Various symptoms including fever
(100%), headache (75.3%), vomiting (55.6%), nausea (53.1%), and
backache (30.9%) were observed among these patients. Throm-
bocytopenia (< 100/109platelets/L), and leucopenia (WBC count
< 4,000 109cells/L) and hemo concentration (hematocrit >45)
were reported in 86.4, 69.1, and 67.9% of the Patients, respec-
tively. High alanine aminotrans-ferase (ALT, >65 U/L) and aspartate
aminotrans-ferase (AST > 37 U/L) were seen in 9.9 and14.8% of the
patients, respectively. There were ﬁve (6.1%) deaths, three of them
had DHF and the other two patients had DSS.
Conclusion: The current study showed that the majority of the
dengue patients were adult, with the male gender preponderance.
DHF and DSS were observed in 58 and 11.1%, respectively. The
mortality rate was 6.1%.
http://dx.doi.org/10.1016/j.ijid.2014.03.908
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Background: Staggering economic booming was seen during
the past decades in BRICS countries, which was referred as Brazil,
Russia, India, China and South Africa. However, what did not
correspond with the economic development was the enormous
increasing of income inequality across varied aspects in the soci-
ety and the emerging challenges due to epidemiological transition
of disease type. As such, information on trends in inequalities is
needed to understand its effects on the burden of infectious dis-
eases.
Methods & Materials: A systematic extensive literature review
search in PubMed and A Medline search with the MeSH term using
terms relevant to “inequalities indices and NTDs and/or EIDs bur-
den and programmes” and other search terms were used to ensure
as much cross-country comparability as possible, HDI, GINI and GII
are based primarily on international data from the United Nations
Population Division, the United Nations Educational, Scientiﬁc and
Cultural Organization (UNESCO), Institute for Statistics (IS) and the
World Bank. Analysis was performed using SPSS 19.0.
Results: A total of 1401 full publications were scrutinized of
which 250 were deemed relevant. Results showed that economic
growth correlated with poverty reduction in all BRICS countries.
The level of inequality may play a critical role in poverty reduction
and diseases burden. The GINI coefﬁcient was found the highest in
South Africa (63.1), followed by Brazil (51.9) and China (47.4). The
IHDI was similar in Brazil (0.531) and China (0.543). The MPI was
found the highest in India(0.283%), and followed by China (0.056)
and South Africa(0.057), whereas the population leaving in less
than $1.25 dollars was more signiﬁcant in India 32.7% and similar
in China and South Africa(13.1 vs 13.8%) contributing to different
degree to the emergence and spread of the vicious cycle of poverty
related diseases.
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Conclusion: Findings call for urgent pragmatic commitment,
measures andevidence informed strategies and programmes-
planning. Meanwhile efforts towards understanding contextual
trend in epidemiology of emerging infectious and neglected tropi-
cal diseases in eachmember country is needed through operational
research and research in achieving the goal of the London declara-
tion and the Millennium Development Goals.
http://dx.doi.org/10.1016/j.ijid.2014.03.909
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Background: Bioenhancers are agents when combined with an
active drug lead to potentiate the pharmacological effect of the
drug but themselves are not having any therapeutic effect. Recent
development in bioavailability enhancement of drugs by herbal
compounds has produced a new shift in the way of therapeutics.
Bioenhancers improvepermeability and inﬂuencebioavailability of
the drug for therapeutic efﬁcacy which may result into decrease in
dose ensuring therapeutic availability. The major problems associ-
ated with the anti-TB drug therapy include loss of efﬁcacy through
bacterial resistance, side effects, and low patient compliance. In
the cited research work, we have attempted to solve the above
mentioned problems by simultaneous use of both the concepts
of microsphere drug delivery (higher bioavailability) and herbal
bioenhancers (improved bioavailability).
Methods & Materials: Methods: Complex coacervation and
modiﬁed emulsion method.
Material: Isoniazid and rifampicin as a model drug used in TB
therapy. Hydro-alcoholic extracts of Carum carvi and Ocimum sanc-
tum were used as bioenhancer.
Results: The in-vitro drug release of isoniazid and rifampicin
from formulations where bioenhancer extract is used was found
to be about 85-90% in 12hrs. While the same was about 45-50%
in case of formulations where bioenhancers were not used. Other
parameters like percentage bioadhesion, permeability study using
intestinal sac method etc. were also studied.
Conclusion: For microspheres prepared by both complex coac-
ervation and modiﬁed emulsion methos, the particle size was
uniform and found to be less than 130 micron in size; the particle
size may alter on addition of bioenhancer extract to the formu-
lations. The drug encapsulation efﬁciency was found to be in the
range of 43-67% (increased on addition of bioenhancer in the for-
mulations). The percentage bioadhesion of the microsphere where
bioenhancers were used found to increase by 20% as compared to
basal value (upto 67% from 42%). The in- vitro release study by USP
paddle apparatus and the most important results from the in-vitro
release study relates to the very signiﬁcant enhancement in drug
release (45 to 90% for microspheres prepared by modiﬁed emul-
sion method and 47 to 90% complex coacervation method), due to
presence of bioenhancers alone and in combination.
http://dx.doi.org/10.1016/j.ijid.2014.03.910
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Background: Every year more than 24000 deaths are reported
due to severeDengueFever (DF)worldwide. Theexactpathogenetic
mechanismsof severity ofDengue Fever (DF) is still not clear. In this
study we attempted to estimate some biomarkers as risk factors
associated with severity of DF.
Methods & Materials: It was a prospective observational case
control study conducted at AIIMS Hospital. We estimated serum
level of TNF-alpha, IL-6 and sTM among shock and non-shock
patients at the time of 1st visit either as OPD patients or at the
time of admission and followed them up till death, discharge(for
admitted patients) or 14 days (for OPD patients).
Results: The mean age of Dengue shock patients was 28.9±10.8
years and themeanageofnon-shockwas29.2±10.9years.Outof 30
shockpatients 20 (66.7%)weremale andamongnon-shock35(70%)
were male. Mean value of sTM was 15.8±6.4 ng/ml among shock
(case) and 6.4±4.4 ng/ml among non-shock (control) and the dif-
ference was highly statistically signiﬁcant (p<0.001). Higher serum
level of sTM (>15 ng/ml) were found among 21 cases (70%) from
shock(case) group and 3 cases (6%) from non-shock(control) which
was also found to have statistically signiﬁcant (<0.001). About 12
cases (39.9%) from shock and 10 cases (20%) from non-shock were
detected to have elevated TNF-alpha (>100 pg/ml) which was not
found to have statistical signiﬁcant (<0.12). About 11 cases (37.7%)
from shock and 15 cases (30%) from non-shock were found to have
elevated IL-6 (>100 pg/ml) which was also not found to have sta-
tistically signiﬁcant (<0.09). We found 22% incidence (11) of shock
among Dengue Fever (non-shock) during follow up for 14 days. We
found signiﬁcant higher base level of serumsTM (13±4.67) and IL-6
(136±76.4) among these 22% (11) patients those who had normal
blood pressure at the 1st visit but subsequently developed shock
during follow up.
Conclusion: sTM and IL-6 both biomarkers could be useful for
predicting Severe Dengue Fever well in advance before develop-
ment of shock or severe DF.
http://dx.doi.org/10.1016/j.ijid.2014.03.911
